These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8938527)

  • 1. Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.
    Ross AA; Layton TJ; Ostrander AB; Passos-Coelho JL; Davis JM; Huelskamp AM; Noga SJ; Davidson NE; Kennedy MJ; Cooper BW; Gerson SL; Lazarus HM; Holland K; Gluck S; Moss TJ; Kaubish A; Vahdat L; Antman K
    J Hematother; 1996 Oct; 5(5):549-52. PubMed ID: 8938527
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.
    Krüger W; Kröger N; Tögel F; Badbaran A; Renges H; Gieseking F; Gutensohn K; Jänicke F; Zander AR
    J Hematother Stem Cell Res; 2001 Apr; 10(2):303-7. PubMed ID: 11359677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of contaminating tumor cells by RT-PCR in breast cancer patients.
    Vannucchi AM; Glinz S; Bosi A; Fallai C; Rossi-Ferrini P
    Bone Marrow Transplant; 1999 Jul; 24(2):228-9. PubMed ID: 10455359
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplantation of CD34+ hematopoietic progenitor cells.
    Shpall EJ; Jones RB; Bearman SI; Purdy MH; Franklin WA; Heimfeld S; Berenson RJ
    J Hematother; 1994; 3(2):145-7. PubMed ID: 7522899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor evaluation and hematotherapy: what is the situation in 1998?
    Sharp JG
    J Hematother; 1998 Apr; 7(2):103-4. PubMed ID: 9597566
    [No Abstract]   [Full Text] [Related]  

  • 6. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
    Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
    Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.
    Rizzo JD; Williams S; Wu JT; Pecora AL; Lazarus HM; Bolwell B; Fields KK; Gale RP; Elfenbein G; Horowitz MM; Antman KH
    Bone Marrow Transplant; 2003 Jul; 32(2):151-5. PubMed ID: 12838279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor contamination in stem cell products from patients with neuroblastoma and breast cancer.
    Moss TJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S17. PubMed ID: 8899162
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety.
    Zimmerman TM; Williams SF; Bender JG; Lee WJ; Blake M; Carreon J; Swinney P; Smith SJ; Schilling M; Oldham F
    J Hematother; 1995 Dec; 4(6):527-9. PubMed ID: 8846012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
    Shpall EJ; Jones RB; Bearman SI; Stemmer SM; Purdy MH; Heimfeld S; Berenson RJ
    Stem Cells; 1993 Oct; 11 Suppl 3():48-9. PubMed ID: 7507756
    [No Abstract]   [Full Text] [Related]  

  • 14. CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma.
    Marabelle A; Merlin E; Halle P; Paillard C; Berger M; Tchirkov A; Rousseau R; Leverger G; Piguet C; Stephan JL; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2011 Jan; 56(1):134-42. PubMed ID: 21058288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
    Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
    J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation.
    Cottler-Fox M; Cipolone K; Yu M; Berenson R; O'Shaughnessy J; Dunbar C
    Exp Hematol; 1995 Apr; 23(4):320-2. PubMed ID: 7534711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapy.
    Kleinman MB; Wiley EL; Guo M; Rademaker AW; Villa M; Tallman MS; Newman SB; Gordon LI; Winter JN
    Bone Marrow Transplant; 1999 Jun; 23(12):1297-301. PubMed ID: 10414919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
    Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
    J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.